These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26292627)

  • 1. Appropriate models for novel osteoporosis drug discovery and future perspectives.
    Gennari L; Rotatori S; Bianciardi S; Gonnelli S; Nuti R; Merlotti D
    Expert Opin Drug Discov; 2015; 10(11):1201-16. PubMed ID: 26292627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for osteoporosis.
    Feurer E; Chapurlat R
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):385-95. PubMed ID: 24995794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in models for screening potential osteoporosis drugs.
    Merlotti D; Materozzi M; Picchioni T; Bianciardi S; Alessandri M; Nuti R; Gennari L
    Expert Opin Drug Discov; 2018 Aug; 13(8):741-752. PubMed ID: 29869573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic targets for osteoporosis: beyond denosumab.
    Lim V; Clarke BL
    Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of post-menopausal osteoporosis: beyond bisphosphonates.
    Ishtiaq S; Fogelman I; Hampson G
    J Endocrinol Invest; 2015 Jan; 38(1):13-29. PubMed ID: 25194424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives in the treatment and prevention of osteoporosis.
    Gennari L; Merlotti D; Nuti R
    Drugs Today (Barc); 2009 Aug; 45(8):629-47. PubMed ID: 19927228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential new drug targets for osteoporosis.
    Deal C
    Nat Clin Pract Rheumatol; 2009 Jan; 5(1):20-7. PubMed ID: 19098925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future therapeutic targets in osteoporosis.
    Deal C
    Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on osteoporosis therapies.
    Cairoli E; Zhukouskaya VV; Eller-Vainicher C; Chiodini I
    J Endocrinol Invest; 2015 Mar; 38(3):303-11. PubMed ID: 25577263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic therapies for osteoporosis.
    Uihlein AV; Leder BZ
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of drug development for the prevention and treatment of osteoporosis.
    Schwarz P; Jørgensen NR; Abrahamsen B
    Expert Opin Drug Discov; 2014 Mar; 9(3):245-53. PubMed ID: 24490672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.
    Estell EG; Rosen CJ
    Nat Rev Endocrinol; 2021 Jan; 17(1):31-46. PubMed ID: 33149262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of osteoporosis treatment - a research update.
    Lippuner K
    Swiss Med Wkly; 2012; 142():w13624. PubMed ID: 22815185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of osteoporosis medications on fracture healing.
    Hegde V; Jo JE; Andreopoulou P; Lane JM
    Osteoporos Int; 2016 Mar; 27(3):861-871. PubMed ID: 26419471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapeutic targets for osteoporosis treatment.
    Chen M; Qiao H; Su Z; Li H; Ping Q; Zong L
    Expert Opin Ther Targets; 2014 Jul; 18(7):817-31. PubMed ID: 24766518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New understanding and treatments for osteoporosis.
    Mazziotti G; Bilezikian J; Canalis E; Cocchi D; Giustina A
    Endocrine; 2012 Feb; 41(1):58-69. PubMed ID: 22180055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoanabolics and the forthcoming drugs for the treatment of osteoporosis].
    Grazio S
    Reumatizam; 2014; 61(2):95-9. PubMed ID: 25427402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders.
    Henriksen K; Thudium CS; Christiansen C; Karsdal MA
    Expert Opin Ther Targets; 2015; 19(11):1575-84. PubMed ID: 25960169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development.
    Li H; Xiao Z; Quarles LD; Li W
    Curr Med Chem; 2021; 28(8):1489-1507. PubMed ID: 32223730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment needs and current options for postmenopausal osteoporosis.
    Gennari L; Rotatori S; Bianciardi S; Nuti R; Merlotti D
    Expert Opin Pharmacother; 2016 Jun; 17(8):1141-52. PubMed ID: 27055223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.